Balfour Beatty plc (LON:BBY – Get Free Report) insider Leo Quinn sold 317,071 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of GBX 448 ($5.81), for a total value of £1,420,478.08 ($1,842,145.09).
Balfour Beatty Trading Down 1.2 %
Shares of LON:BBY opened at GBX 436 ($5.65) on Tuesday. The company has a market capitalization of £2.22 billion, a P/E ratio of 1,038.10, a P/E/G ratio of 3.75 and a beta of 0.81. Balfour Beatty plc has a 1 year low of GBX 305.40 ($3.96) and a 1 year high of GBX 458 ($5.94). The company has a debt-to-equity ratio of 79.17, a current ratio of 0.99 and a quick ratio of 0.84. The business’s 50 day simple moving average is GBX 430.78 and its 200 day simple moving average is GBX 400.33.
Balfour Beatty Cuts Dividend
The business also recently declared a dividend, which will be paid on Friday, December 6th. Investors of record on Thursday, October 31st will be given a dividend of GBX 3.80 ($0.05) per share. This represents a yield of 0.93%. The ex-dividend date of this dividend is Thursday, October 31st. Balfour Beatty’s dividend payout ratio is currently 2,857.14%.
Analyst Upgrades and Downgrades
View Our Latest Analysis on Balfour Beatty
Balfour Beatty Company Profile
Balfour Beatty plc finances, designs, develops, builds, and maintains infrastructure in the United Kingdom, the United States, and internationally. It operates through three segments: Construction Services, Support Services, and Infrastructure Investments. The company constructs buildings, including commercial, healthcare, education, retail, and residential assets; and infrastructure assets comprising highways and railways, as well as other large-scale infrastructure assets, such as waste, water, and energy plants.
Featured Articles
- Five stocks we like better than Balfour Beatty
- What Does a Stock Split Mean?
- Intel: Is Now the Time to Be Brave?
- Why Invest in High-Yield Dividend Stocks?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Why Invest in 5G? How to Invest in 5G Stocks
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Balfour Beatty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balfour Beatty and related companies with MarketBeat.com's FREE daily email newsletter.